Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 8

1.

Hypoxia and defective apoptosis drive genomic instability and tumorigenesis.

Nelson DA, Tan TT, Rabson AB, Anderson D, Degenhardt K, White E.

Genes Dev. 2004 Sep 1;18(17):2095-107. Epub 2004 Aug 16.

2.

Impact of proapoptotic proteins Bax and Bak in tumor progression and response to treatment.

Cartron PF, Juin P, Oliver L, Meflah K, Vallette FM.

Expert Rev Anticancer Ther. 2003 Aug;3(4):563-70. Review.

PMID:
12934667
3.

PUMA, a potent killer with or without p53.

Yu J, Zhang L.

Oncogene. 2008 Dec;27 Suppl 1:S71-83. doi: 10.1038/onc.2009.45. Review.

4.

Apoptosis regulators and their role in tumorigenesis.

Zörnig M, Hueber A, Baum W, Evan G.

Biochim Biophys Acta. 2001 Oct 1;1551(2):F1-37. Review.

PMID:
11591448
5.

Hypoxia-induced genetic instability--a calculated mechanism underlying tumor progression.

Huang LE, Bindra RS, Glazer PM, Harris AL.

J Mol Med (Berl). 2007 Feb;85(2):139-48. Epub 2006 Dec 20. Review.

PMID:
17180667
6.

Endoreplication and polyploidy: insights into development and disease.

Fox DT, Duronio RJ.

Development. 2013 Jan 1;140(1):3-12. doi: 10.1242/dev.080531. Review.

7.

Guidelines for the selection of functional assays to evaluate the hallmarks of cancer.

Menyhárt O, Harami-Papp H, Sukumar S, Schäfer R, Magnani L, de Barrios O, Győrffy B.

Biochim Biophys Acta. 2016 Dec;1866(2):300-319. doi: 10.1016/j.bbcan.2016.10.002. Epub 2016 Oct 11. Review.

8.

Using mice to unveil the genetics of cancer resistance.

van der Weyden L, Adams DJ.

Biochim Biophys Acta. 2012 Dec;1826(2):312-30. doi: 10.1016/j.bbcan.2012.05.003. Epub 2012 May 19. Review.

PMID:
22613679

Supplemental Content

Support Center